netFormulary NHS
North Central London
Joint Formulary
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Chapter
07.01  Drugs used in obstetrics
07.01.01  Prostaglandins and oxytocics
Carbetocin
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Prevention of postpartum haemorrhage due to uterine atony following C-section
 
   
Carboprost
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Obs and Gynae only
  • RFL:
    • Restricted to Obs and Gynae only
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
   
Dinoprostone (Propess®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Obstetrics and Gynaecology Consultants only for induction and Augmentation of Labour
  • RFL:
    • See ‘Induction of Labour’ policy on Freenet
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Dinoprostone (Prostin E2®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • See ‘Induction of Labour’ policy on Freenet
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Vaginal gel 1 mg/2.5 ml (Prostin E2), Vaginal gel 2 mg/2.5 ml (Prostin E2) Inj 5 mg/0.5 ml extra amniotic
 
Link  RFL: Royal Free Maternity Unit Guideline for Induction of Labour
   
Ergometrine maleate
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Obstetrics Only 
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Ergometrine maleate + Oxytocin (Syntometrine®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Restricted to Obstetrics ONLY
  • RFL:
    • See Maternity Unit Guideline on Massive Obstetric Haemorrhage
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Misoprostol
(Gynae)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

NOTE: There is more than one monograph for misoprostol tablets, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to Obs and Gynae
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Oxytocin
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Induction (IOL) and Augmentation of Labour
  • RFL:
    • See ‘Induction of Labour’ policy on Freenet
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
Link  RFL: Maternity Unit Guideline for Induction of Labour
   
07.01.01.01  Drugs affecting the ductus arteriosus
07.01.01.01  Maintenance of patency
07.01.01.01  Closure of ductus arteriosus to top
Ibuprofen IV injection (Pedea®)
(Ductus arteriosus)
View adult BNF View SPC online View childrens BNF
Formulary
  • NMUH:
    • Refer to SPC
  • RFL:
    • Restricted to neonatal unit
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.01.02  Mifepristone
Mifepristone
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Obstetrics and Gynaecology Consultants only.
    • Mifepristone must be collected from pharmacy and signed for by a qualified midwife or nurse. 
  • RFL:
    • Restricted to Obstetrics and Gynaecology Consultants only.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Mifepristone 200 mg tablets are for specialist use only
 
   
07.01.03  Myometrial relaxants
Atosiban
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Not a preferred choice agent
    • See ‘Pre-Term Labour’ policy on Freenet
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Atosiban is to be used only in accordance with protocol
 
Link  RFL: Maternity Unit Guideline for Pre-Term Labour
   
Salbutamol IV
(Obstetrics)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Terbutaline injection
(obstetrics)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • For obstetric use only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.02  Treatment of vaginal and vulval conditions
07.02.01  Preparations for vaginal and vulval changes
07.02.01  Topical HRT to top
Estradiol 10mcg vaginal tablet (Vagifem®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Severe vulvar and vaginal atrophy in patients with a history of breast cancer 
 
   
Estradiol 7.5mcg /24hrs 7.5 microgram/24 hours vaginal delivery system (Estring®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Estriol 0.01% vaginal cream (Gynest®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • For Gynae (HRT) and Paediatrics (labial adhesions) only 
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Estriol 1mg/1g vaginal cream (Ovestin®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
07.02.01  Non-hormonal preparations
07.02.02  Vaginal and vulval infections
07.02.02  Fungal infections
Clotrimazole
(Vaginal candidiasis)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Only 1% cream, 200mg Pessaries and 500mg Pessaries stocked
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Pessaries available as 200 mg & 500 mg
 
   
Ketoconazole 2% cream
(Gynaecology)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Miconazole 20mg/g vaginal cream (Gyno-Daktarin®)
(Gynaecology)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.02.02  Other vaginal infections
Clindamycin 2% vaginal cream (Dalacin®)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Dequalinium chloride vaginal tablets
View adult BNF View SPC online View childrens BNF
Formulary

Approved for bacterial vaginosis as a second-line alternative to clindamycin 2% intravaginal cream in patients who have not tolerated or failed metronidazole treatment (JFC August 2018).

Provider notes

  • NMUH:
    • Restricted to GU medicine ONLY
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As above
 
   
Metronidazole 0.75% vaginal gel (Zidoval®)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
07.03  Contraceptives to top
07.03.01  Combined hormonal contraceptives
Ethinylestradiol / levonorgestrel phased pill 21-days (TriRegol®, Logynon®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Preferred brand = Logynon
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ethinylestradiol / levonorgestrel phased pill 28-days (Logynon ED®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Ethinylestradiol 20 mcg / norethisterone 1mg pill 21-days (Loestrin 20®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Ethinylestradiol 20mcg / desogestrel 150mcg pill 21-days (Bimizza®, Gedarel 20/150®, Mercilon®, Munalea 20/150®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY = Gedarel 20/150
    • Preferred brand for Obs & Gynae = Mercilon
  • RFL:
    • Preferred brand = Munalea
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Preferred brand = Mercilon
    • The CSM has advised that combined contraceptives containing gestodene or desogestrel should not be used by women with risk factors for venous thromboembolism (for further information see BNF). For other women a levonorgestrel or norethisterone-containing product is also generally the initial choice. But the statement by the Department of Health on 7 April, 1999 acknowledges the tiny difference in VTE risk between theses and those containing desogestrel. “Women must be fully informed of these very small risks. The type of pill provided is for the women together with her doctor or other family planning professionals jointly to decide in the light of her individual medical history.”
 
   
Ethinylestradiol 20mcg / gestodene 75 mcg pill 21-days (Aidulan 20/75®, Femodette®, Millinette 20/75®, Sunya®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Preferred brand = Millinette 20/75
    • Millinette 20/75 is restricted to Consultants in GU Medicine ONLY
  • RFL:
    • Preferred brand = Aidulan
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ethinylestradiol 30 mcg / drospirenone 3 mg pill 21-days (Lucette®, Yasmin®, Yiznell®, other brands available)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Not approved for oral contraception (JFC, February 2016)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Preferred brands = Lucette®, Yiznell® and Yasmin®
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ethinylestradiol 30 mcg / norethisterone 1.5mg pill 21-days (Loestrin 30®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ethinylestradiol 30mcg / desogestrel 150mcg pill 21-days (Gedarel 30/150®, Marvelon®, Munalea 30/150®, other brands available)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY = Gedarel 30/150
    • Preferred brand for Obs & Gynae = Marvelon
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Preferred brand = Marvelon
    • The CSM has advised that combined contraceptives containing gestodene or desogestrel should not be used by women with risk factors for venous thromboembolism (for further information see BNF). For other women a levonorgestrel or norethisterone-containing product is also generally the initial choice. But the statement by the Department of Health on 7 April, 1999 acknowledges the tiny difference in VTE risk between theses and those containing desogestrel. “Women must be fully informed of these very small risks. The type of pill provided is for the women together with her doctor or other family planning professionals jointly to decide in the light of her individual medical history.”
 
   
Ethinylestradiol 30mcg / gestodene 75 mcg pill 21-days (Aidulan 30/75®, Femodene®, Katya®, other brands available)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY = Millinette 30/75
    • Preferred brand for Obs & Gynae = Femodene
  • RFL:
    • Preferred brand = Aidulan
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Preferred brands = Femodene
    • Millinette 30/75= for Community Clinics ONLY
    • The CSM has advised that combined contraceptives containing gestodene or desogestrel should not be used by women with risk factors for venous thromboembolism (for further information see BNF). For other women a levonorgestrel or norethisterone-containing product is also generally the initial choice. But the statement by the Department of Health on 7 April, 1999 acknowledges the tiny difference in VTE risk between theses and those containing desogestrel. “Women must be fully informed of these very small risks. The type of pill provided is for the women together with her doctor or other family planning professionals jointly to decide in the light of her individual medical history.”
 
   
Ethinylestradiol 30mcg / levonorgestrel 150mcg pill 21-days (Microgynon 30®, Rigevidon®, Maexeni®, other brands available)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Restricted to GU Medicine ONLY = Rigevidon
    • For Obs & Gynae = Microgynon 30
  • RFL:
    • Preferred brands = Maexeni, Rigevidon, Microgynon 30
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Preferred brand = Microgynon 30
    • Rigevidon= Formulary item for Community Trust
 
   
Ethinylestradiol 30mcg / levonorgestrel 150mcg pill 28-days (Microgynon 30 ED®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ethinylestradiol 35 mcg / norgestimate 250 mcg pill 21-day (Cilique®, Cilest®, Lizinna®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Preferred brand = Cilest
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • There is insufficient information to know if there is an increased risk associated with norgestimate.
 
   
Norelgestromin / ethylestradiol patch (Evra®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Approved for control of menstrual disturbances in adolescents in whom the combined oral contraceptive is appropriate, however, cannot take oral medicines, for example, patients with physical and learning difficulties, or tube feeding (JFC August 2016)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted, see approved indication above
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • See approved indication above
 
   
07.03.01  Emergency contraception
07.03.02  Progestogen-only contraceptives
Norethisterone 350mcg pill  (Micronor®, Noriday®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Micronor has been discontinued

Provider notes

  • NMUH:
    • Preferred brand = Micronor
  • RFL:
    • Preferred brand = Noriday
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Preferred brand = Micronor
 
   
07.03.02.01  Oral progestogen-only contraceptives
Desogestrel 75mcg pill (generic, Cerazette®, Cerelle®, other brands available)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Preferred brand = generic
    • Restricted to Consultants in GU Medicine ONLY
  • RFL:
    • Preferred brand = generic
    • Approved for Sexual Health and Family
    • Approved for Gynaecology
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Cerelle or generic
 
   
07.03.02.02  Parenteral progestogen-only contraceptives to top
Medroxyprogesterone acetate 150mg IM injection (Depo-Provera®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
First Choice
GP - 1st

First-choice parenteral progestogen-only contraceptive (JFC July 2019)

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Depo-Provera is licensed for short and long-term contraceptive use and is given every 12 weeks. Injectable progestogens effectively inhibit ovulation, in addition to effects on the endometrium and cervical mucus
 
Etonogestrel 68mg subdermal implant (Nexplanon®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - 2nd

Second-choice parenteral progestogen-only contraceptive (JFC July 2019)

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY.
    • Check for MHRA Drug Safety Updates
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As above
 
   
07.03.02.03  Intra-uterine progestogen-only contraceptive
Intra-uterine levonorgestrel system (Mirena®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY
    • Check MHRA Drug Safety Updates
  • RFL:
    • Preferred choice
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Intra-uterine levonorgestrel system (Kyleena®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Approved as first-line intra-uterine device for contraception (February 2019)

Provider notes

  • NMUH:
    • To be used as above
    • Restricted to sexual health clinics
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As above
 
   
Intra-uterine levonorgestrel system (Levosert®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Formulary

Approved as first-line intra-uterine device for (JFC March 2018):

  • heavy menstrual bleeding
  • contraception

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Preferred choice
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • As above
 
   
07.03.03  Spermicidal contraceptives
Nonoxinol-9 2% spremicidal gel (Gygel®)
(Contraceptive)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU medicines ONLY
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.03.04  Contraceptive devices
07.03.04  Intra-uterine devices
Intra-uterine Contraceptive Devices (Mini TT 380 Slimline®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Intra-uterine Contraceptive Devices (Nova-T® 380)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Intra-uterine Contraceptive Devices (T-Safe® 380A QuickLoad)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Obs & Gynae and GU Consultants ONLY
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Intra-uterine Contraceptive Devices (TT 380® Slimline)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.03.04  Other contraceptive devices to top
07.03.05  Emergency Contraception
07.03.05  Hormonal methods
Levonorgestrel 1.5mg tablet
(Emergency contraception)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY
    • Check MHRA drug safety updates
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Ulipristal 30mg tablet (EllaOne®)
(Emergency contraception)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Approved for emergency contraception (JFC July 2019)

Provider notes

  • NMUH:
    • Restricted to Consultants in GU Medicine ONLY
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Second line treatment for those who are intolerant of GnRH analogues
 
   
07.03.05  Intra-uterine device
07.04  Drugs for genito-urinary disorders
07.04.01  Drugs for urinary retention to top
07.04.01  Alpha-blockers
Alfuzosin immediate release
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Alfuzosin modified release
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Restricted to Urology Department, second line use only.
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of alfuzosin is reserved for the Urology Department only
 
   
Doxazosin
(Urology)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Modified release preparations are non-formulary
  • RFL:
    • Modified release preparations are non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Modified release praparations are non-formulary
 
   
Indoramin
(Urology)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Restricted to Urology use only
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Prazosin
(Urology)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Patients are usually given a low first dose of prazosin at bedtime, as postural hypotension may occur. The dose is then gradually increased if tolerated
 
   
Tamsulosin modified release
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of tamsulosin are reserved for the Urology Department only.
 
   
07.04.01  Parasympathomimetics
07.04.02  Drugs for urinary frequency, enuresis, and incontinence
07.04.02  Urinary incontinence
Botulinum toxin Type A (Botox®)
(Urinary retention)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red

NOTE: There is more than one monograph for Botulinum toxin type A, click here to search for formulary status and its use for other indications. 

Not approved for urinary retention due to a disorder of the urethral sphincter (JFC October 2019)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to urology only
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Duloxetine (Yentreve®)
(Urinary incontinence)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Duloxetine (Yentreve) is FORMULARY for use in women with moderate to severe urinary stress incontinence. Duloxetine (Yentreve) should be used as a second line option for urinary stress incontinence, as an alternative to surgical treatment, as per NICE guidance.
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Mirabegron
View adult BNF View SPC online View childrens BNF
Formulary

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • This medicine has a positive NICE Technology Appraisal and is listed in the Trust Medicines Formulary when used in line with NICE recommendations and/or Local Trust Guidelines.
    • Check MHRA Drug Safety Update
  • RFL:
    • For overactive bladder as per NICE TA
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
Link  NICE TA290: Mirabegron for overactive bladder
   
Oxybutynin immediate release
(Urinary incontinence)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • First line for urinary incontinence.
  • RFL:
    • No restriction stated (liquid not available)
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Please refer to NCL JFC guidelines for the pharmacological management of overactive bladder (OAB) syndrome in primary care
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Oxybutynin modified release
(Urinary incontinence)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
   
Oxybutynin patch (Kentera®)
(Urinary incontinence)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Only to be used in patients who are unable to take oral medications Review effective treatment annually (or every 6 months in patient ≥ 75 years old) and consider a 4 week ‘drug free holiday’ to avoid chronic adverse effects. (NCL JFC May 2016)
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Propantheline
(Hyperhidrosis; Adult enuresis)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Solifenacin
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • As per JFC guidance on the treatment of overactive bladder
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Tolterodine immediate release
(Urinary incontinence)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Due to its increased cost, the use of tolterodine is reserved for those patients unable to tolerate oxybutynin
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Tolterodine modified release
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • No restriction stated
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Trospium
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NCL JFC: Pharmacological management of Overactive Bladder (OAB) Syndrome in Primary Care
   
Botulinum toxin Type A (Botox®)
(Neurogenic detrusor overactivity, Overactive bladder)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Red

NOTE: There is more than one monograph for Botulinum toxin type A, click here to search for formulary status and its use for other indications. 

Approved for neurogenic bladder dysfunction for patients refractory to oral therapies (JFC January 2013)

Provider notes

  • NMUH:
    • Botox brand only
    • Restricted to consultants Dr Yoong, Mr Nair and Mr Godbole for use in Overactive Bladder (OAB) only
  • RFL:
    • Restricted to urology only
  • RNOH:
    • Restricted to Consultant Urologists only for neurogenic detrusor overactivity
  • UCLH:
  • WH:
    • See Botulinum Toxin Management Algorithm Diagram for direction of use
 
   
07.04.02  Nocturnal enuresis to top
07.04.03  Drugs used in urological pain
07.04.03  Alkalinisation of urine
Sodium Bicarbonate
(Alkalinisation of urine)
View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Alkalinisation of urine with sodium bicarbonate or potassium citrate can relieve discomfort lower urinary tract e.g. cystitis. Potassium citrate should be used with caution in renal impairment,
      or cardiac disease as hyperkalaemia may occur with prolonged usage at high doses.
 
   
Sodium Citrate sachet/powder
(Alkalinisation of urine)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Sodium Citrate 0.3Molar solution available
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Potassium Citrate
(Alkalinisation of urine)
View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Potassium Citrate mixture 1.5g/5mL (also contains citric acid 250mg/5mL) and Effercitrate® tablets available
    • Renal tubular disorders - Urocit-K® used
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Alkalinisation of urine with sodium bicarbonate or potassium citrate can relieve discomfort lower urinary tract e.g. cystitis. Potassium citrate should be used with caution in renal impairment,
      or cardiac disease as hyperkalaemia may occur with prolonged usage at high doses.
 
   
07.04.03  Acidification of urine
Ascorbic Acid (Vitamin C)
(Urology)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Acidification may prevent encrustation of indwelling catheters, excess mucus formation in bladder augmentation and urinary tract infections. Many patients find high dose ascorbic acid unpalatable and may prefer to take cranberry juice drinks that are now widely available in the high street.
 
   
07.04.03  Other preparations for urinary disorders
07.04.04  Bladder instillations and urological surgery to top
Sodium hyaluronate (Hyacyst®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

Not approved for Interstitial cystitis (JFC February 2017)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for interstitial cystitis
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.04.04  Urological surgery
Glycine 1.5% Irrigation Solution
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Available as 3L bags
  • RNOH:
    • Available as 3000 mL bags
  • UCLH:
  • WH:
    • No restriction stated
 
   
07.04.04  Maintenance of indwelling urinary catheters
Chlorhexidine acetate 0.02% catheter maintenance solution
View adult BNF View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Sodium chloride 0.9% catheter maintenance solution
View adult BNF View childrens BNF
Formulary

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • No restriction stated
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
07.04.05  Drugs for erectile dysfunction
07.04.05  Alprostadil
Alprostadil intracavernous injection (Caverject®)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:
    • Red List Medicine – Hospital Only Prescribing
  • RFL:
    • Restricted to Urology and Endocrinology consultants
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Inj 20 micrograms only
 
   
Alprostadil intracavernous injection (Viridal® Duo)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Restricted to Urology and Endocrinology Consultants
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Alprostadil urethral stick (MUSE®)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 

Provider notes

  • NMUH:

    • Red List Medicine – Hospital Only Prescribing Restricted to Consultants in Urology and Sexual Health (St. Ann's) use only.
  • RFL:
    • Restricted to Urology and Endocrinology Consultants
  • RNOH:

    • Non-formulary
  • UCLH:
  • WH:

    • Non-formulary
 
   
07.04.05  Phosphodiesterase type 5 inhibitors to top
Sildenafil
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Grey for SLS indications

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

 

Provider notes

  • NMUH:
    • Urology consultant only.
  • RFL:
    • Restricted to Urology and Endocrinology
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • The use of sildenafil tablets are restricted to consultant urologists and diabetologists only in accordance with NICE guidelines.
 
Tadalafil (10mg, 20mg)
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Grey for SLS indications

Tadalafil when required (PRN) is second-line treatment for erectile dysfuction only if idiosyncratic reaction to sildenafil (SLS indications only).

Tadalfil daily is not recommended.

 

Provider notes

  • NMUH:
    • Second-line option, after failure with sildenafil or following idiosyncratic reactions with sildenafil. To be prescribed/recommended by the urology team only.
  • RFL:
    • For Urology and Endocrinology use only.
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NCL JFC Position statement: Daily tadalafil tablets (Cialis®)
Link  NICE TA273: Hyperplasia (benign prostatic) - tadalafil (terminated appraisal)
   
07.04.05  Papaverine and phentolamine
Aviptadil + phentolamine (Invicorp®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
GP - Amber

Erectile dysfunction in men who have failed to respond to oral PDE5i (sildenafil and tadalafil) and intracavernosal/urethral alprostadil. Secondary care initiation, primary care continuation (SLS only) (JFC November 2017)

Provider notes

  • NMUH:
    • To be prescribed by Urology Consultants ONLY. To be used as a second line option after treatment failure or intolerance with oral PDE5i (tadalafil or sildenafil) and intracavernosal/ urethral alprostadil.
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Approved by NCL as 2nd line treatment for erectile dysfuntion if alprostadil fails (JFC November 2016)
 
   
Papaverine
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • No restriction stated
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
   
Phentolamine
(Erectile dysfunction)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for Phentolamine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary
 
   
07.04.06  Drugs for premature ejaculation
07.04.06  Dapoxetine
07.05  Other urology indications
07.06  Unlicensed Medicines / Significant off-label use to top
Acetylcysteine
(Renal protection)
View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Ephedrine tablets
(Priapism in sickle cell disease)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Approved for use for priapism (unlicensed use).
    • See links below
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
Link  NMUH: Sickle cell guidelines for adult patients
Link  NMUH: Sickle cell guidelines for paediatric patients
   
Indometacin suppositories
(Tocolytic)
View adult BNF View SPC online View childrens BNF
Formulary
GP - Red

Approved for tocolytic therapy during pre-natal repair of myelomeningocele, a serious form of spina bifida (UCLH only; JFC February 2018)

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
    • As tocolytic therapy during pre-natal repair of myelomeningocele (fetal spina bifida) (UMC Dec 2017)
  • WH:
    • Non-formulary
 
   
Metformin
(Polycystic ovaries syndrome)
View adult BNF View SPC online View childrens BNF
Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • No restriction stated
  • RFL:
    • Gynaecology and Endocrinology only
  • RNOH:
    • Non-formulary
  • UCLH:
    • No restriction stated
  • WH:
    • Non-formulary
 
   
Methotrexate injection
(Ectopic pregnancy)
View childrens BNF
Formulary
GP - Red

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Provider notes

  • NMUH:
    • Zlatal is stocked. This is a licensed preparation, but it is not licensed for use in ectopic pregnany
  • RFL:
    • See local protocol
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • No restriction stated
 
   
Sodium thiosulfate inj
(Calciphylaxis)
View adult BNF View SPC online View childrens BNF
Formulary

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for calciphylaxis (off-label use)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Etilefrine
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed

Provider notes

  • NMUH:
    • For treatment of priapism in patients with sickle cell disease
    • Etilefrine 25mg Tablets, available from ‘special-order’ manufacturers or specialist importing companies
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Tiopronin
(Urological stones)
Restricted Drug Restricted

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Approved for urological stones in patients with cysteine urea
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
 ....
 Non Formulary Items
Alprostadil 3mg/g cream  (Vitaros®)
(Erectile dysfunction)

View adult BNF View SPC online View childrens BNF
Non Formulary

GP-RedRed (hospital only prescribing) if used for non-SLS indications

Amber for SLS indications

 
Alprostadil infusion  (Prostin VR®)
(Maintain the patency)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Anethol, Borneol, Camphene, Cineole, Fenchone, Pinene  (Rowatinex®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Avanafil

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for Erectile Dysfunction (JFC July 2014 & February 2015)

 
Bethanechol Chloride

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Collagenase injection
(Peyronie's disease)

View adult BNF View SPC online View childrens BNF
Non Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

Approved for Peyronie's disease, funding to be agreed following submission of a NCL business case to Commissioners (JFC October 2016).

Product has been withdrawn.

 
Dapoxetine

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for premature ejaculation (February 2014)

 
Darifenacin

View adult BNF View SPC online View childrens BNF
Non Formulary
 
DIMETHYL SULPHOXIDE Bladder Instillation 50%
(DMSO)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Domperidone
(Lactation stimulation)

View childrens BNF
Non Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

 
Dutasteride + Tamsulosin  (Combodart®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Econazole  (Gyno-Pevaryl®)
(Gynaecology)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Estradiol 1.5 mg / nomegestrol 2.5 mg pill 28-days  (Zoely®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol / dienogest phased pill 28-days  (Qlaira®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol / etonogestrel vaginal contraceptive  (NuvaRing®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol / norethisterone phased pill 21-days  (Synphase®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol 20 mcg / drospirenone 3 mg pill 28-days  (Eloine®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol 30mcg / gestodene 75 mcg pill 28-days  (Femodene® ED)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol 35 mcg / noresthisterone 1mg 21-days  (Norimin®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ethinylestradiol 35 mcg / noresthisterone 500mcg 21-days  (Brevinor®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fenticonazole  (Gynoxin®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fertility (ovulation) thermometer
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Fesoterodine modified release

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for overactive bladder (October 2012)

 
Flavoxate

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Gemeprost

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Imipramine
(Urinary frequency)

View adult BNF View SPC online View childrens BNF
Non Formulary

NOTE: There is more than one monograph for this medicine, click here to search for formulary status and its use for other indications. 

 
Intra-uterine Contraceptive Devices  (Ancora® 375 Ag)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Ancora® 375 Cu)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Copper T 380A®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Cu-Safe®T300)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Flexi-T® 300)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Flexi-T® + 380)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (GyneFix®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Load® 375)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Multiload® Cu375)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Multi-Safe® 375)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Multi-Safe® 375 Short Stem)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Neo-Safe® T380)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Novaplus T 380® Ag)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (Novaplus T 380® Cu)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (UT 380 Short®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine Contraceptive Devices  (UT 380 Standard®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Intra-uterine levonorgestrel system  (Jaydess®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary

Not a recommended intra-uterine device for contraception; Kyleena is preferred (JFC February 2019)

 
Lactic acid  (Balance Activ Rx®)
(Bacterial vaginosis)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lactic Acid  (Relactagel®)
(Bacterial vaginosis)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Levonorgestrel 30mcg pill  (Norgeston®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lidocaine-Heparin Bladder Instillation  (Parsons solution)
(Interstitial cystitis​)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red

Interim approval (restricted for specialist urology use only pending service review) (February 2017)

 
Medroxyprogesterone acetate 104mg SC injection  (Sayana Press®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Mestranol 50 mcg / norethisterone 1mg 21-days  (Norinyl-1®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Misoprostol vaginal delivery system  (Mysodelle®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for induction of labour in women with an unfavourable cervix (May 2016)

 
Norethisterone enantate 200mg IM injection  (Noristerat®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Oxybutynin Intra-vesical
(5mg/30ml)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Pentosan polysulfate sodium caps  (Elmiron®)

View adult BNF View SPC online View childrens BNF
Non Formulary
GP - Red

See NICE TA for eligibility criteria

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
Link  NICE TA610: Pentosan polysulfate sodium for treating bladder pain syndrome
 
Propiverine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Replens MD ®

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ritodrine  (Yutopar®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Rubber contraceptive diaphragms
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Silicone contraceptive pessary
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sodium Citrate 3% irrigation solution
(Bladder irrigation)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Solifenacin + Tamsulosin  (Vesomni®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not approved for lower Urinary Tract Symptoms (October 2014)

 
Solution G catheter maintenance solution

View adult BNF View childrens BNF
Non Formulary
 
Solution R catheter maintenance solution

View adult BNF View childrens BNF
Non Formulary
 
Spermicidal Contraceptives  (Ortho-Creme®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Spermicidal Contraceptives  (Orthoforms®)
(Contraceptive)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tadalafil (2.5mg, 5mg)  (Erectile dysfunction)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Once daily preparation is not approved for erectile dysfunction (January 2015)
Once daily preparation is not approved post nerve-sparing radical prostatectomy (NSRP) (January 2015)

Link  NCL JFC: Daily Tadalafil Tablets Position Statement
Link  NICE TA273 (not recommended): Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)
 
Terazosin
(Benign prostatic hyperplasia)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type A contraceptive pessary
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type A diaphragm with flat metal spring
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type B contraceptive pessary
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type B diaphragm with coiled metal rim
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type C arcing spring diaphragm
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Type C contraceptive pessary
(Contraception)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Vardenafil

View adult BNF View SPC online View childrens BNF
Non Formulary

GP-RedRed (hospital only prescribing) if used for non-SLS indications

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. 

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.  

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

See link for the complete NCL Red List https://www.ncl-mon.nhs.uk/wp-content/uploads/2017/08/ncl_red_list.pdf

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary